Etiology Study of Kawasaki Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00154596

Recruitment Status : Recruiting

First Posted : September 12, 2005

Last Update Posted : March 17, 2015

See Contacts and Locations

Sponsor:

Information provided by (Responsible Party):

National Taiwan University Hospital

Study Description

Brief Summary:

The purpose of this study is to investigate the infectious etiology of Kawasaki disease (KD); a prospective household and case control study for Kawasaki disease will be done. The investigators will enroll Kawasaki disease cases who have at least five of the following manifestations:

fever for over 5 days
neck lymphadenopathy
lip fissure and/or strawberry tongue
skin rash
nonpurulent bulbar conjunctivitis
palm/sole erythema and induration followed by desquamation, or coronary artery aneurysm with less than 5 of the above manifestations (atypical Kawasaki disease)

The KD cases will receive virological (virus isolation from the blood, throat swabs and rectal swabs or stool, gene chip for possible viruses from stored RNA and DNA), bacterial (blood, throat swabs and stool: bacterial culture and stored strain for further toxin or superantigen detection), and serological (Mycoplasma pneumoniae, Chlamydiae pneumoniae, ASLO, HHV6, EV71, peptide library approach for auto-antibody or pathogen-related antibody, stored serum for further workup) workup. Stored DNA from the blood will also be performed.

Condition or disease
Kawasaki Disease

Show Detailed Description

Study Design


Study Type :	Observational
Estimated Enrollment :	700 participants
Observational Model:	Case Control
Time Perspective:	Prospective
Official Title:	Etiology Study of Kawasaki Disease--A Prospective Household and Case Control Study
Study Start Date :	February 2004
Estimated Primary Completion Date :	December 2018
Estimated Study Completion Date :	December 2018

Resource links provided by the National Library of Medicine

Genetics Home Reference related topics: Kawasaki disease

MedlinePlus related topics: Kawasaki Disease

Genetic and Rare Diseases Information Center resources: Kawasaki Disease

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :

Viral infections associated with Kawasaki disease [ Time Frame: 2014/3 ]
The mean age of the 226 KD cases was 2.07 years, and the male to female ratio was 1.43 (133 boys to 93 girls). Their mean fever duration was 7.5 days with a mean peak temperature of 39.7°C. In addition to the typical symptoms of fever, neck lymphadenopathy, lip fissure and/or strawberry tongue, skin rash, nonpurulent bulbar conjunctivitis, palm/sole erythema, and induration followed by periungual desquamation, these KD cases also exhibited cough (69%), rhinorrhea (58%), and diarrhea (45%). Cases of KD had a significantly higher positive rate of viral isolation in comparison with the control group (7.5% vs. 2.2%, p = 0.02). Compared with the control group, cases of KD were more likely to have overall positive rates of viral PCR (50.4% vs. 16.4%, p < 0.001) and for various viruses including enterovirus (16.8% vs. 4.4%, p < 0.001), adenovirus (8.0% vs. 1.8%, p = 0.007), human rhinovirus (26.5% vs. 9.7%, p < 0.001), and coronavirus (7.1% vs. 0.9%, p = 0.003).

Biospecimen Retention: Samples With DNA

Blood, throat swab, nasopharyngeal aspiration, and rectal swab will be obtained during acute illness and at convalescence (about 2 weeks after discharge). These specimens will be processed for viral isolation, bacterial culture and toxin detection, PCR, subtractive cloning, VIDISCA, gene chips, peptide library, cytokine/chemokine measurement, antibody detection for specific pathogens, etc. Questionnaire for contact history and clinical symptoms will be performed.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	1 Month to 18 Years (Child, Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

We will enroll Kawasaki disease cases who have at least five of the following manifestations: 1) fever for over 5 days, 2) neck lymphadenopathy, 3) lip fissure and/or strawberry tongue, 4) skin rah, 5) nonpurulent bulbar conjunctivitis, 6) palm/sole erythema and induration followed by desquamation, or cases with coronary artery aneurysm but less than 5 of the above manifestations (atypical Kawasaki disease).

Criteria

Inclusion Criteria:

Patients who fulfill the criteria of Kawasaki disease or atypical Kawasaki disease and their household family members

Exclusion Criteria:

Not cases of Kawasaki disease

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00154596

Contacts


Contact: Luan-Yin Chang, MD, PhD	886-2-23123456 ext 3245	ly7077@tpts6.seed.net.tw

Locations


Taiwan
National Taiwan University Hospital	Recruiting
Taipei, Taiwan, 100
Contact: Luan-Yin Chang, MD, PhD 886-2-23123456 ext 3245 ly7077@tpts6.seed.net.tw
Principal Investigator: Luan-Yin Chang, MD, PhD

Sponsors and Collaborators

National Taiwan University Hospital

Investigators


Principal Investigator:	Luan-Yin Chang, MD, PhD	National Taiwan University Hospital

More Information

Publications of Results:

Chang LY, Chiang BL, Kao CL, Wu MH, Chen PJ, Berkhout B, Yang HC, Huang LM; Kawasaki Disease Research Group. Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis. 2006 Jan 15;193(2):283-6. Epub 2005 Dec 2.

Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, Cheng AL, Lee WL, Hu JJ, Yeh SJ, Chang CC, Chiang BL, Wu MH, Huang LM. Viral infections associated with Kawasaki disease. J Formos Med Assoc. 2014 Mar;113(3):148-54. doi: 10.1016/j.jfma.2013.12.008. Epub 2014 Feb 1.

Tsai HC, Chang LY, Lu CY, Shao PL, Fan TY, Cheng AL, Hu JJ, Yeh SJ, Chang CC, Huang LM. Transmission of acute infectious illness among cases of Kawasaki disease and their household members. J Formos Med Assoc. 2015 Jan;114(1):72-6. doi: 10.1016/j.jfma.2014.07.005. Epub 2014 Sep 6.

Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, Liang CD, Chi H, Huang FY, Lee ML, Huang YC, Hwang B, Chiu NC, Hwang KP, Lee PC, Chang LC, Liu YM, Chen YJ, Chen CH; Taiwan Pediatric ID Alliance, Chen YT, Tsai FJ, Wu JY. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet. 2012 Mar 25;44(5):522-5. doi: 10.1038/ng.2227.


Responsible Party:	National Taiwan University Hospital
ClinicalTrials.gov Identifier:	NCT00154596 History of Changes
Other Study ID Numbers:	930004318
First Posted:	September 12, 2005 Key Record Dates
Last Update Posted:	March 17, 2015
Last Verified:	March 2015

Keywords provided by National Taiwan University Hospital:


etiology transmission vasculitis household etiology of disease

Additional relevant MeSH terms:


Mucocutaneous Lymph Node Syndrome Vasculitis Vascular Diseases Cardiovascular Diseases	Lymphatic Diseases Skin Diseases, Vascular Skin Diseases

To Top